Oxetanyl Sulfoxide MMS-350 Ameliorates Pulmonary Fibrosis In Vitro, In Vivo, and Ex Vivo-Reference-Cited by-同舟云学术

Oxetanyl Sulfoxide MMS-350 Ameliorates Pulmonary Fibrosis In Vitro, In Vivo, and Ex Vivo

Published:2020-09-10 Issue:11 Volume:11 Page:2312-2317
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Mlakar Logan¹,Lane Jessica¹,Takihara Takahisa²,Lim Chaemin³,Sprachman Melissa M.³,Lloyd Kayla R.³,Wipf Peter³^ORCID,Feghali-Bostwick Carol¹^ORCID

Affiliation:

1. Department of Medicine, Division of Rheumatology & Immunology, Medical University of South Carolina, Charleston, South Carolina 29425, United States

2. Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa 259-1193, Japan

3. Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States

Funder

National Institutes of Health

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00433

Reference14 articles.

1. Recent Advances in the Development of Small-Molecule Inhibitors for Idiopathic Pulmonary Fibrosis (IPF)

2. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

3. Changes in causes of death in systemic sclerosis, 1972-2002

4. Drugs and Targets in Fibrosis

5. Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxetanes in Drug Discovery Campaigns;Journal of Medicinal Chemistry;2023-09-07

2. Design, synthesis and biological evaluation studies of novel anti-fibrosis agents bearing sulfoxide moiety;Bioorganic & Medicinal Chemistry;2022-12

3. Antifibrotic pyridine-containing monoterpene alkaloids from Caryopteris glutinosa;Phytochemistry;2022-11